Skip to main content
Premium Trial:

Request an Annual Quote

ChemAxon Tapped to Provide Software for European Drug Discovery Consortium

Premium

ChemAxon said recently that it will provide cheminformatics software for the European Lead Factory, an international consortium of 30 partners that provides access to small molecules and compounds that could be used to develop new medicines.

Specifically, ChemAxon will use components of its JChem Base, Discovery, and Marvin toolkits to build a portal through which the consortium will be able to track, score, and analyze submitted proposals for new drug compounds.

With an expected budget of about €196 million ($255 million), the European Lead Factory is supported by the Innovative Medicines Initiative and comprises small and medium-sized enterprises, academic institutions, and large pharmaceutical companies. It is developing a compound library that will contain about 500,000 compounds derived from public and private collections, which it will make available to project partners and public organizations.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.